At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Apnea Rampant In Acute Decompensated Heart Failure II
In Brief
A Phase 4 clinical trial evaluating Autotitrating Positive Airway Pressure for Heart Failure and Sleep Apnea Syndromes. Completed, enrolled 6 participants across 1 site.
Detailed Summary
Heart Failure affects 5-6 million Americans and there are about 550 thousand new cases of heart failure every year. There are approximately 3 million hospital admission for acute decompensated heart failure with hospital readmission rate of 20% at 30 days and 50% at 60 day, costing up to 20 billion dollars per year. In our previous study we have discovered that sleep disordered breathing is prevalent in 70% of patients with acute decompensated heart failure. We hypothesize that, detection and treatment of sleep disordered breathing in acute decompensated heart failure patients will reduce episodic hypoxic events during acute decompensation and may decrease hospital length of stay and reduce future readmissions.
Study Details
Timeline
Interventions
Patients will be treated with Autotitrating Positive Airway Pressure therapy